Clinical and Experimental Pediatrics

대한소아청소년과학회 (The Korean Pediatric Society)
권호 표지
DOI QR코드

DOI QR Code

Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia

  • Park, Young Shil (Department of Pediatrics, Kyung Hee University Hospital at Gangdong, School of Medicine, Kyung Hee University)
  • 투고 : 2021.05.24
  • 심사 : 2021.06.21
  • 발행 : 2021.08.15
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The development of vaccines against severe acute respiratory syndrome coronavirus 2, which features high mortality and morbidity rates, has progressed at an unprecedented rate, and vaccines are currently in use worldwide. Thrombotic events after vaccination are accompanied by thrombocytopenia, and this issue was recently termed vaccine-induced immune thrombotic thrombocytopenia. This manuscript describes recently published guidelines and other related issues and demonstrates characteristic cases.

키워드

참고문헌

  1. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA 2020;324:782-93. https://doi.org/10.1001/jama.2020.12839
  2. World Health Organization. Coronavirus disease (COVID-19) [Internet]. Geneva (Switzerland): World Health Organization; 2021 [cited 2021 Jun 15]. Available from: https://extranet.who.int/pqweb/vaccines/covid-19-vaccines.
  3. U.S. Food and Drug Administration. COVID-19 vaccines [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2021 [cited 2021 May 15]. Available from: https://www.fda.gov/emergency-preparednessand-response/coronavirus-disease-2019-covid-19/covid-19-vaccines.
  4. European Medicine Agency. COVID-19 vaccines [Internet]. Amsterdam (Netherlands): European Medicine Agency; 1995-2021 [cited 2021 May 5]. Available from: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatmentsvaccines/covid-19-vaccines.
  5. Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021;397:99-111. https://doi.org/10.1016/S0140-6736(20)32661-1
  6. Sadoff J, Gray G, Vandebosch A, Cardenas V, Shukarev G, Grinsztejn B, et al. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. N Engl J Med 2021;384:2187-201. https://doi.org/10.1056/NEJMoa2101544
  7. Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med 2021;384:2092-101. https://doi.org/10.1056/NEJMoa2104840
  8. Schultz NH, Sorvoll IH, Michelsen AE, Munthe LA, Lund-Johansen F, Ahlen MT, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. N Engl J Med 2021;384:2124-30. https://doi.org/10.1056/NEJMoa2104882
  9. Warkentin TE, Cuker A. COVID-19: vaccine-induced immune thrombotic thrombocytopenia (VITT) [Internet]. Waltham (MA): UpToDate; 2021 [cited 2021 Jun 15]. Available from: https://www.uptodate.com/contents/covid-19-vaccine-induced-immune-thrombotic-thrombocytopenia-vitt?search=COVID-19:%20vaccine-induced%20immune%20thrombotic%20thrombocytopenia%20(VITT)&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1.
  10. Nazy I, Sachs UJ, Arnold DM, McKenzie SE, Choi P, Althaus K, et al. Recommendations for the clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia (VITT) for SARS-CoV-2 infections: Communication from the ISTH SSC Subcommittee on Platelet Immunology. J Thromb Haemost 2021;19:1585-8. https://doi.org/10.1111/jth.15341
  11. International Society on Thrombosis and Haemostasis. ISTH Interim Guidance for the Diagnosis and Treatment on Vaccine-Induced Immune Thrombotic Thrombocytopenia (Updated 20 April, 2021) [Internet]. Carrboro (NC): ISTH; 2021 [cited 2021 Jun 15]. Available from: https://www.isth.org/resource/resmgr/ISTH_VITT_Guidance_2.pdf.
  12. Oldenburg J, Klamroth R, Langer F, Albisetti M, von Auer C, Ay C, et al. Diagnosis and management of vaccine-related thrombosis following AstraZeneca COVID-19 vaccination: guidance statement from the GTH. Hamostaseologie 2021;41:184-9. https://doi.org/10.1055/a-1469-7481
  13. Guidance produced by the Expert Haematology Panel (EHP) focussed on Vaccine induced Thrombosis and Thrombocytopenia (VITT) [Internet]. London: British Society for Haematology; 2021 [cited 2021 Jun 15]. Available from: https://b-s-h.org.uk/about-us/news/guidance-producedby-the-expert-haematology-panel-ehp-focussed-on-vaccine-inducedthrombosis-and-thrombocytopenia-vitt/.
  14. Muir KL, Kallam A, Koepsell SA, Gundabolu K. Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. N Engl J Med 2021;384:1964-5. https://doi.org/10.1056/NEJMc2105869
  15. Medicines and Healthcare products Regulatory Agency. Coronavirus vaccine - weekly summary of Yellow Card reporting - Data included: 09/12/2020 to 05/04/2021 [Internet]. GOV.UK; 2021 [cited 2021 Jun 15]. Available from: https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting.
  16. Update: Thrombosis with thrombocytopenia syndrome (TTS) following COVID-19 vaccination [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2021 [cited 2021 Jun 15]. Available from: https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-05-12/07-COVID-Shimabukuro-508.pdf.
  17. Shin SM. Second case of thrombocytopenic thrombosis in South Kore. YONHAP NEWS [Internet]. 2021 Jun 16 [cited 2021 Jun 16]. Available from: https://www.yna.co.kr/view/AKR20210616107651530?input=1195m.
  18. National Advisory Committee on Immunization (NACI). An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) [Internet]. Ottawa (ON): Public Health Agency of Canada; 2021 [cited 2021 Jun 15]. Available from: https://www.canada.ca/content/dam/phac-aspc/documents/services/immunization/nationaladvisory-committee-on-immunization-naci/recommendations-usecovid-19-vaccines/recommendations-use-covid-19-vaccines-en.pdf.
  19. Gras-Champel V, Liabeuf S, Baud M, Albucher JF, Benkebil M, Boulay C, et al. Atypical thrombosis associated with VaxZevria (AstraZeneca) vaccine: data from the French Network of Regional Pharmacovigilance Centres. Therapie 2021:S0040-5957(21)00130-X.
  20. Cines DB, Bussel JB. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. N Engl J Med 2021;384:2254-6. https://doi.org/10.1056/NEJMe2106315
  21. Greinacher A. Heparin-induced thrombocytopenia. N Engl J Med 2015;373:252-61. https://doi.org/10.1056/NEJMcp1411910
  22. Warkentin TE. Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia. Thromb Haemost 2016;116:813-22. https://doi.org/10.1160/TH16-06-0435
  23. Obeng EA, Harney KM, Moniz T, Arnold A, Neufeld EJ, Trenor CC. Pediatric heparin-induced thrombocytopenia: prevalence, thrombotic risk, and application of the 4Ts scoring system. J Pediatr 2015;166:144-50. https://doi.org/10.1016/j.jpeds.2014.09.017
  24. See I, Su JR, Lale A, Woo EJ, Guh AY, Shimabukuro TT, et al. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021. JAMA 2021;325:2448-56. https://doi.org/10.1001/jama.2021.7517
  25. Arepally GM, Ortel TL. Vaccine-induced immune thrombotic thrombocytopenia (VITT): what we know and don't know. Blood 2021:blood.2021012152.
  26. Thaler J, Ay C, Gleixner KV, Hauswirth AW, Cacioppo F, Grafeneder J, et al. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT). J Thromb Haemost 2021;19:1819-22. https://doi.org/10.1111/jth.15346
  27. Carli G, Nichele I, Ruggeri M, Barra S, Tosetto A. Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine. Intern Emerg Med 2021;16:803-4. https://doi.org/10.1007/s11739-021-02685-0
  28. Lee EJ, Cines DB, Gernsheimer T, Kessler C, Michel M, Tarantino MD, et al. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination. Am J Hematol 2021;96:534-7. https://doi.org/10.1002/ajh.26132
  29. Helms JM, Ansteatt KT, Roberts JC, Kamatam S, Foong KS, Labayog JS, et al. Severe, refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccine. J Blood Med 2021;12:221-4. https://doi.org/10.2147/JBM.S307047
  30. Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost 2020;18:1023-6. https://doi.org/10.1111/jth.14810
  31. Iba T, Levy JH, Levi M, Thachil J. Coagulopathy in COVID-19. J Thromb Haemost 2020;18:2103-9. https://doi.org/10.1111/jth.14975
  32. Mitchell WB, Davila J, Keenan J, Jackson J, Tal A, Morrone KA, et al. Children and young adults hospitalized for severe COVID-19 exhibit thrombotic coagulopathy. Pediatr Blood Cancer 2021;68:e28975.
  33. Whi worth HB, Sartain SE, Kumar R, Armstrong K, Ballester L, Betensky M, et al. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood 2021;blood.2020010218.